Cargando…
Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263364/ https://www.ncbi.nlm.nih.gov/pubmed/37324497 http://dx.doi.org/10.3389/fphar.2023.1219760 |
| _version_ | 1785058225684480000 |
|---|---|
| author | Herrmann, Franziska Elena Hesslinger, Christian Wollin, Lutz Nickolaus, Peter |
| author_facet | Herrmann, Franziska Elena Hesslinger, Christian Wollin, Lutz Nickolaus, Peter |
| author_sort | Herrmann, Franziska Elena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10263364 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102633642023-06-15 Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis Herrmann, Franziska Elena Hesslinger, Christian Wollin, Lutz Nickolaus, Peter Front Pharmacol Pharmacology Frontiers Media S.A. 2023-05-30 /pmc/articles/PMC10263364/ /pubmed/37324497 http://dx.doi.org/10.3389/fphar.2023.1219760 Text en Copyright © 2023 Herrmann, Hesslinger, Wollin and Nickolaus. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Herrmann, Franziska Elena Hesslinger, Christian Wollin, Lutz Nickolaus, Peter Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis |
| title | Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis |
| title_full | Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis |
| title_fullStr | Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis |
| title_full_unstemmed | Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis |
| title_short | Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis |
| title_sort | corrigendum: bi 1015550 is a pde4b inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263364/ https://www.ncbi.nlm.nih.gov/pubmed/37324497 http://dx.doi.org/10.3389/fphar.2023.1219760 |
| work_keys_str_mv | AT herrmannfranziskaelena corrigendumbi1015550isapde4binhibitorandaclinicaldrugcandidatefortheoraltreatmentofidiopathicpulmonaryfibrosis AT hesslingerchristian corrigendumbi1015550isapde4binhibitorandaclinicaldrugcandidatefortheoraltreatmentofidiopathicpulmonaryfibrosis AT wollinlutz corrigendumbi1015550isapde4binhibitorandaclinicaldrugcandidatefortheoraltreatmentofidiopathicpulmonaryfibrosis AT nickolauspeter corrigendumbi1015550isapde4binhibitorandaclinicaldrugcandidatefortheoraltreatmentofidiopathicpulmonaryfibrosis |